Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1 - Wikidata - awgldk - TriplyDB

Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1

Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1

http://www.wikidata.org/entity/Q36385275

about

Molecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisal Regulation of brown adipocyte metabolism by myostatin/follistatin signaling Reducing the burden of obesity-associated cancers with anti-inflammatory long-chain omega-3 polyunsaturated fatty acids TNF-alpha induces TGF-beta1 expression in lung fibroblasts at the transcriptional level via AP-1 activation.Prothrombotic State in Asthma Is Related to Increased Levels of Inflammatory Cytokines, IL-6 and TNFα, in Peripheral Blood.Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions Impact of early fructose intake on metabolic profile and aerobic capacity of rats.Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1 TNF-alpha and adipocyte biology.Cardiovascular risks in obesity.Autoamplification of tumor necrosis factor-alpha: a potential mechanism for the maintenance of elevated tumor necrosis factor-alpha in male but not female obese mice Monocyte chemoattractant protein 1 in obesity and insulin resistance.Tumor necrosis factor alpha mediates apoptosis of brown adipocytes and defective brown adipocyte function in obesity Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk.Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling Plasminogen activator inhibitor 1 (PAI-1): in vitro activities and clinical relevance.Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases.Adipocytes Promote B16BL6 Melanoma Cell Invasion and the Epithelial-to-Mesenchymal Transition Adipose tissue and atherothrombosis.Effects of weight loss and pharmacotherapy on inflammatory markers of cardiovascular disease.Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway.Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation.Biomarkers of obesity and subsequent cardiovascular events Chronic sub-clinical inflammation in the abdominal adipose tissue - Evaluation of inflammatory cytokines and their link with insulin resistance in metabolically obese South Indians: A cross-sectional observational study.Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.Identification and modulation of a caveolae-dependent signal pathway that regulates plasminogen activator inhibitor-1 in insulin-resistant adipocytes Imaging of atherosclerotic plaques in obesity: excessive fat accumulation, plaque progression and vulnerability.The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity.Impact of vitamin A on high-density lipoprotein-cholesterol and scavenger receptor class BI in the obese rat.Intrinsic heterogeneity in adipose tissue of fat-specific insulin receptor knock-out mice is associated with differences in patterns of gene expression.Divergent roles for p55 and p75 TNF-alpha receptors in the induction of plasminogen activator inhibitor-1.The Use of Silk as a Scaffold for Mature, Sustainable Unilocular Adipose 3D Tissue Engineered Systems.Plasminogen activator inhibitor links obesity and thrombotic cerebrovascular diseases: The roles of PAI-1 and obesity on stroke.Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression.Tumor necrosis factor-alpha induces transforming growth factor-beta1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway.Characterisation of receptor-specific TNFalpha functions in adipocyte cell lines lacking type 1 and 2 TNF receptors.Pentoxifylline improves liver regeneration through down-regulation of TNF-α synthesis and TGF-β1 gene expression.Molecular and cellular mechanisms of adipose secretion: comparison of leptin and angiotensinogen.Metabolic syndrome signs in Wistar rats submitted to different high-fructose ingestion protocols.Treatment with a Catalytic Superoxide Dismutase (SOD) Mimetic Improves Liver Steatosis, Insulin Sensitivity, and Inflammation in Obesity-Induced Type 2 Diabetes.

P2860

Q26783344-9DDE2441-C37F-4E35-B8D8-0A702DDAB7E5 Q26863660-09C21D56-571E-445D-9A39-6974EED83A90 Q28076327-C6FAAF97-AB04-485E-B529-91511CB6155F Q33793939-78A33894-82E5-4A18-B3CE-0A4634826859 Q33862178-B475D411-BB09-4765-AF07-9A44447FA319 Q34217461-4E74A886-B8D0-4AA0-A2DC-1D3EA5809427 Q34506534-9B4E4044-73E7-4E65-9D32-87131009A545 Q34996841-10E85D11-8970-4C08-B0CF-C1DCC7450CAB Q35006572-B144E3FA-6489-4B4F-835F-1BCCE65F4275 Q35037276-96C9BBF1-59A3-4C97-B8DF-9257350C417B Q35087900-FA99FECA-7F03-49B3-A9FF-5231AE66ABCC Q35163496-81E57687-4BFA-414F-8FF5-5297092F9946 Q35175151-E6E56289-9EC9-4E25-827E-DC23B4CD383A Q35181647-A388051D-5387-482D-9998-81FEE114A679 Q35203175-AA9A0BEF-ACCA-4D07-A7E9-0EA104DB1029 Q35688843-01FC7989-39FB-45D1-8998-C5E84CE78D5A Q35721055-90B8981A-49C5-4614-BB51-12D107CC8513 Q35931354-78744830-2602-425E-A257-85ECDE193083 Q36030434-E09F0B2C-22F8-440B-A214-6BB3FF00F848 Q36216863-CD4B2D0A-6F25-4685-96D4-2A02246E22FB Q36306603-96AF84C2-40AB-4678-A726-FF425B41FB98 Q36327607-FDAA1636-8179-41FB-8041-C6F5CBE7C79D Q36381096-EA3849AF-67A6-4CA3-A4CE-457DE276A568 Q36550333-42A719D3-DA1A-401C-8E8A-8ABF4397BB9D Q36861002-39381FBC-C415-4991-9A1C-C625180229B6 Q37704701-CA55463E-FB67-483C-BCC6-562614CA6D6D Q38263804-3C4F0AAD-9343-45FA-872D-25744C89D9CE Q38302172-12367B3E-C397-4E7F-82B5-9F097C7B0359 Q38304734-8498BA63-B78F-4BB0-AB9D-D1382AD9A792 Q38341516-8CBEA696-3DBC-46A8-8F8C-7FC5E9E3C462 Q38357414-BDFE1F9D-6E07-4395-91A1-3B395DE01F29 Q38865117-EEA64BDC-831E-43AF-BE94-116FB5BADBA0 Q39220804-BFA33540-5654-4CB0-BC2C-4EC6232C2467 Q40287159-8BDCDBA0-A973-4126-94C9-5193E00F0F43 Q40470243-FE582E47-9E77-4E1B-9965-C8B2A1DD8EED Q40894968-C46FC7B6-038C-43C1-AA4D-5F6FB68ED4F6 Q41916844-499717DA-1635-41A8-95CD-A00408A85F80 Q43704466-A9344304-00E3-425B-A353-FEDD56E46EA9 Q46248238-0908F143-FA7B-46E1-ABE9-9B3DFED4F769 Q46268603-10A513F2-4E1A-400C-953A-DBE56DA7DEB0

P2860

Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1

http://www.wikidata.org/entity/Q36385275

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh

1999年學術文章

@zh-hant

name

Tumor necrosis factor alpha is ...... sminogen activator inhibitor 1

@ast

Tumor necrosis factor alpha is ...... sminogen activator inhibitor 1

@en

type

label

Tumor necrosis factor alpha is ...... sminogen activator inhibitor 1

@ast

Tumor necrosis factor alpha is ...... sminogen activator inhibitor 1

@en

prefLabel

Tumor necrosis factor alpha is ...... sminogen activator inhibitor 1

@ast

Tumor necrosis factor alpha is ...... sminogen activator inhibitor 1

@en

P1433

Q36385275-A6BDF12D-44A8-4ED0-8211-A74CB44BD96C

P1476

Q36385275-65DFBD53-0B08-4EB7-A589-0C7200ACD91F

P2093

Q36385275-343AC1C2-8D2D-4E3B-A312-970611A5232E

Q36385275-A2C51051-2454-4DA9-A658-899DDA59B09C

Q36385275-AFD5EA83-98DB-4A9F-9478-0CD43EA58841

Q36385275-B590F89D-AD92-4FCE-A2F3-EA19D3651AF3

Q36385275-B5B9938D-B94A-438B-A397-8B33BD209DAB

Q36385275-F0FA263C-D849-4A5A-83DA-843147949F39

P2860

Q36385275-015507E4-5A56-4F4D-BF6D-7A7E098C892A

Q36385275-02ACF024-5B7D-49F7-AC14-3777BA72EBF8

Q36385275-03A2D84D-936E-4F9C-9F55-A672901BDD62

Q36385275-0D519E9F-41A1-456E-A5DA-2E4EB824492F

Q36385275-0E9861BD-09FD-40B6-89FA-4BCDE64E3718

Q36385275-123C88B0-6EC0-4D86-8764-D886B6FA7FC3

Q36385275-1352FE33-B5D5-4CFA-A456-C6E7F75222BC

Q36385275-1AC4A477-5F72-4391-AC80-93E2E89A4F5F

Q36385275-1B3DE20D-37F8-4B19-BA82-4864CE677746

Q36385275-1DB6806E-9B37-4311-990F-18B63AC3FB48

P304

Q36385275-A21917BF-3BBE-4E82-AAAE-C145C43FA428

P31

Q36385275-864A909D-DA64-48F1-B270-B32810501243

P356

Q36385275-18E78057-9783-49FA-B436-E3C72DFCBCD4

P407

Q36385275-C36B8749-E850-4518-B39A-C8BB4E4E441D

P433

Q36385275-90A9FB39-BE80-4629-BDD3-DAEDC3A19172

P478

Q36385275-3989A284-29DC-43F2-A41E-030755CAE9C3

P577

Q36385275-9D219EFD-F2B0-43CF-805F-E1D3F0F5DC54

P5875

Q36385275-84871CB8-FD08-49EC-82C1-717D68D6AD3A

P698

Q36385275-2CE63ACD-7625-4ED9-A49D-0003600539E2

P921

Q36385275-077EC423-1CBF-408F-B803-B0159A25646F

P932

Q36385275-248B2B6C-41EC-446C-AB99-443D8C688DF0

P356

PNAS.96.12.6902

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Tumor necrosis factor alpha is ...... sminogen activator inhibitor 1

@en

P2093

D J Loskutoff

http://www.w3.org/2001/XMLSchema#string

F Samad

http://www.w3.org/2001/XMLSchema#string

G S Hotamisligil

http://www.w3.org/2001/XMLSchema#string

K T Uysal

http://www.w3.org/2001/XMLSchema#string

M Pandey

http://www.w3.org/2001/XMLSchema#string

S M Wiesbrock

http://www.w3.org/2001/XMLSchema#string

P2860

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

Abdominal fat distribution and disease: an overview of epidemiological data.

The role of TNF alpha in adipocyte metabolism.

Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.

The metabolic cardiovascular syndrome: syndrome X, Reaven's syndrome, insulin resistance syndrome, atherothrombogenic syndrome.

Two TNF receptors.

Role of tumor necrosis factor alpha in induction of murine CD14 gene expression by lipopolysaccharide

P304

6902-6907

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.96.12.6902

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

1999-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12938774

http://www.w3.org/2001/XMLSchema#string

P698

10359811

http://www.w3.org/2001/XMLSchema#string

P921

P932

22014

http://www.w3.org/2001/XMLSchema#string